Nachrichten zur Pfizer Inc. Aktie

Dividenden-Aktie Pfizer: Milliarden-Deal in China

Der US-amerikanische Pharma-Riese Pfizer verstärkt seine Entwicklungspipeline. Für bis zu 10,5 Milliarden Dollar sichert sich das Unternehmen die Rechte an…

Dividenden-Aktie Pfizer: Milliarden-Deal in China

Der US-amerikanische Pharma-Riese Pfizer verstärkt seine Entwicklungspipeline. Für bis zu 10,5 Milliarden Dollar sichert sich das Unternehmen die Rechte an…

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to develop oncology…

Barclays belässt Pfizer auf Underweight - Ziel 25 Dollar

LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für Pfizer mit einem Kursziel von 25 US-Dollar auf…

Why 1 Wall Street Analyst Thinks Pfizer (PFE) Stock Could Soar 38%

As with other pharma companies, much rides on Pfizers pipeline; it has many promising formulations in late-stage trials.…

Whats the Better Dividend Stock Today: AbbVie or Pfizer?

These healthcare giants have been top dividend stocks for years, and both could be intriguing options to consider right now.…

TNXP: Secures Commercial Payer Coverage for Tonmya® to Provide Access for ~35 Million U.S. Patients

By David Bautz, PhDNASDAQ: TNXPREAD THE FULL TNXP RESEARCH REPORTBusiness UpdateTonmya™ UpdateTonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) is continuing the…

Pfizer Aktie: Trotz Umsatzplus weiter begrenztes Potenzial!

New York (www.aktiencheck.de) - Pfizer-Aktienanalyse von Wolfe Research:Wolfe-Research-Analystin Alexandria Hammond habe das Kursziel für die Aktie von Pfizer Inc. (ISIN:…

PLX: Chiesi Milestone Received

By John Vandermosten, CFANYSE: PLXREAD THE FULL PLX RESEARCH REPORTWhile Protalix BioTherapeutics, Inc. (NYSE: PLX) has been quiet since the…

Pfizer Just Locked In Its Next 5 Years of Growth -- Heres How

The pharmaceutical powerhouse still faces plenty of patent challenges, but it got a big one out of the way, securing…

PFE Stock Declines Post Q1 Beat: Book Profits or Stay Invested?

Pfizer stock slipped after Q1 results despite an earnings beat as investors weighed falling COVID sales and looming patent expirations.…

Top Analyst Reports for Meta, Pfizer & Salesforce

Meta ramps up AI infrastructure and ad tools as Pfizer rebounds and Salesforce expands AI offerings amid macro pressures.…

Pfizer: Dont Pass On This Dirt-Cheap Buying Opportunity

…

Prediction: Pfizer Will Beat the Market Over the Next 5 Years

Its a great time to "buy low."…

Pfizers Net Income Drops in Q1. Is Its Dividend Still Safe?

At 6.7%, Pfizers dividend yield is exceptionally high, but whether its sustainable is debatable.…

Halozyme (HALO) Q1 2026 Earnings Transcript

Image source: The Motley Fool.DateMonday, May 11, 2026 at 4:30 p.m. ETCall participantsChief Executive Officer — Helen TorleyInterim Chief Financial…

Notable healthcare headlines for the week: UnitedHealth, Pfizer, and CVS Health in focus

…

Tomi (TOMZ) Q4 2025 Earnings Transcript

Image source: The Motley Fool.DATEFriday, May 8, 2026 at 4:30 p.m. ETCALL PARTICIPANTSChief Executive Officer — Halden ShaneChief Financial Officer…

Could Buying This Beaten-Down Healthcare Stock Make You Rich If It Recovers?

Pfizer is an innovative pharmaceutical giant that investors have given up on, which is an opportunity if you think long-term.…

Earnings recap: Airbnb, AMD, Shopify, Pfizer, Uber, Arm, Disney…

…

Pfizers 6.5% Dividend Yield Looked Too Good to Be True -- but Management Just Silenced the Skeptics

Is Pfizer a yield trap? No way.…

Novavax (NVAX) Q3 2025 Earnings Transcript

Image source: The Motley Fool.DateThursday, Nov. 6, 2025, at 8:30 a.m. ETCall participantsPresident and Chief Executive Officer — John JacobsHead…

Pfizer’s newer medicines carry more weight in Q1

Pfizer’s first-quarter results gave investors a clearer view of how much work the drugmaker’s newer portfolio is doing as the…

Pfizer Kaufen

FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat die Einstufung für Pfizer nach Zahlen zum ersten Quartal auf "Kaufen" mit…

DZ Bank belässt Pfizer auf Kaufen - Fairer Wert 29 Dollar

FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat die Einstufung für Pfizer nach Zahlen zum ersten Quartal auf "Kaufen" mit…

Pfizer Neutral

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Pfizer auf "Neutral" mit einem Kursziel von 27…

BofA raises Pfizer stock price target on first-quarter beat

BofA raises Pfizer stock price target on first-quarter beat…

JPMorgan belässt Pfizer auf Neutral - Ziel 30 Dollar

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer nach Quartalszahlen auf "Neutral" mit einem Kursziel…

ROUNDUP: Neue und alte Medikamente sorgen für überraschendes Wachstum bei Pfizer

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer ist im ersten Quartal überraschend deutlich gewachsen und…

ROUNDUP: Neue und alte Medikamente sorgen für überraschendes Wachstum bei Pfizer

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer ist im ersten Quartal überraschend deutlich gewachsen und sieht sich auf Kurs…

IQVIA (IQV) Q1 2026 Earnings Call Transcript

Image source: The Motley Fool.DATETuesday, May 5, 2026 at 9 a.m. ETCALL PARTICIPANTSChairman and Chief Executive Officer — Ari BousbibExecutive…

Überraschend starker Start: Neue Medikamente sorgen für Wachstum bei Pfizer

NEW YORK (dpa-AFX) - Der US-Pharmakonzern Pfizer ist im ersten Quartal überraschend deutlich gewachsen und…

Pfizer beats Q1 revenue and profit estimates, reaffirms 2026 guidance

Pfizer Inc (NYSE:PFE, XETRA:PFE) reported first-quarter 2026 revenue and adjusted profit above Wall Street expectations on Tuesday, driven by strong…

Pfizer Aktie: Ausblick bestätigt

Wien (www.aktiencheck.de) - Pfizer-Aktienanalyse der Raiffeisen Bank International AG:Julian Lindinger, Analyst der Raiffeisen Bank International AG (RBI), nimmt in einer…

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Pfizer is looking to newer products and acquisitions to offset a declining Covid business.…

Pfizer beats first quarter estimates on strong product growth

Pfizer beats first quarter estimates on strong product growth…

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

Pfizer on Tuesday reported first-quarter profit ?above Wall Street estimates, boosted by sustained demand for older ?drugs such as blood…

Pfizer Beats on Q1 Earnings, New & Acquired Drugs Drive Sales Growth

Pfizer beats Q1 estimates as new launches and acquired drugs lift sales, offsetting COVID declines, while the drugmaker reaffirms its…

Pfizer Stock: Still Priced Like Its Dead Money

Shares of Pfizer are down 50% from their 2021 high, and the yield is an alluring 6.4%.…

US FDA approves Pfizer, Arvinas’ breast cancer drug

US FDA approves Pfizer, Arvinas’ breast cancer drug…

US FDA approves Pfizer, Arvinas breast cancer drug

The U.S. ?Food and Drug Administration ?on Friday approved Pfizer and Arvinas drug for ?a ?type of breast cancer.…

Goldman Sachs resets Pfizer stock forecast

Pfizer has spent the past few years trying to convince investors that its post-pandemic business can stand on its own,…

Buy, Sell or Hold Pfizer Stock? Key Tips Ahead of Q1 Earnings

Pfizer sees mixed Q1 signals as growth in key drugs offsets COVID declines. Can pipeline strength and M&A bets support…

Pfizer Aktie: Vyndamax-Deal sorgt für Zweifel an Patentstärke

New York (www.aktiencheck.de) - Pfizer-Aktienanalyse von Morgan Stanley:Die Analysten von Morgan Stanley bewerten die Aktie von Pfizer Inc. (ISIN: US7170811035,…

Novo Nordisk vs. Pfizer: Which Healthcare Giant Is the Better Bet?

NVO and PFE clash as the obesity market heats up, with shifting strategies, pipeline bets and growth pressures reshaping their…

Is Pfizers 6% Dividend Yield Safe? Heres What Investors Need to Know.

Pfizers vaccine business cooled off, and it is on its back foot in the GLP-1 race, but dont count the…

Is Pfizers 6% Dividend Yield Safe? Heres What Investors Need to Know.

Pfizers vaccine business cooled off, and it is on its back foot in the GLP-1 race, but dont count the…

Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know

The latest trading day saw Pfizer (PFE) settling at $26.8, representing a -1.87% change from its previous close.…

MRKs sBLAs for Keytruda Combo in Bladder Cancer Get FDA Priority Tag

FDA grants priority review to Mercks sBLAs for Keytruda & Keytruda SC in combination with Pfizers Padcev in cisplatin-eligible MIBC…

A Monthly Weight Loss Shot? Why Pfizer Could Topple Lillys and Novos GLP-1 Duopoly

There might be room for two titans in the obesity business, but a third player might have a uniquely marketable…